Urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in kidney transplant patients.
Pinheiro
H S
HS
Renal Transplantation Unit, Division of Nephrology, Federal University of Juiz de Fora, Minas Gerais, Brazil. helady@terra.com.br
Mituiassu
A M
AM
Carminatti
M
M
Braga
A M
AM
Bastos
M G
MG
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002437:Cefazolin / Q000627:therapeutic use; D004926:Escherichia coli / Q000187:drug effects / Q000235:genetics; D004927:Escherichia coli Infections / Q000453:epidemiology / Q000382:microbiology; D005260:Female; D005921:Glomerulonephritis / Q000150:complications; D006084:Graft Rejection / Q000453:epidemiology; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011183:Postoperative Complications / Q000382:microbiology*; D012008:Recurrence; D012189:Retrospective Studies; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D001618:beta-Lactamases / Q000096:biosynthesis
D000900:Anti-Bacterial Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D001618:beta-Lactamases; D002437:Cefazolin